Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.
2.

Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening.

Kinney W, Sawaya GF, Sung HY, Kearney KA, Miller M, Hiatt RA.

Acta Cytol. 2003 Mar-Apr;47(2):167-71. Review.

PMID:
12685183
3.

Cervical cancer screening. Past success and future challenge.

Dewar MA, Hall K, Perchalski J.

Prim Care. 1992 Sep;19(3):589-606. Review.

PMID:
1410065
4.

Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.

Im DD, Duska LR, Rosenshein NB.

Gynecol Oncol. 1995 Nov;59(2):179-82. Review.

PMID:
7590468
5.

[Endocervical adenocarcinoma in situ. A histological entity to know].

Fignon A, Mayelo V, Wurst C, Magnin G, Tariel D, Descamps P, Renjard L, Body G, Lansac J.

J Gynecol Obstet Biol Reprod (Paris). 1995;24(4):369-73. Review. French.

PMID:
7650312
6.

[Population screening for uterine cervix cancer: the negative effects of insufficient knowledge as to what is normal and abnormal].

van der Graaf Y.

Ned Tijdschr Geneeskd. 2002 Aug 24;146(34):1569-71. Review. Dutch.

PMID:
12224477
7.

Duration of relative protection of screening for cervical cancer.

Celentano DD, Klassen AC, Weisman CS, Rosenshein NB.

Prev Med. 1989 Jul;18(4):411-22. Review.

PMID:
2678092
8.

In vitro conventional cytology historical strengths and current limitations.

Spitzer M.

Obstet Gynecol Clin North Am. 2002 Dec;29(4):673-83. Review.

PMID:
12509091
9.

Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix.

Shipman SD, Bristow RE.

Curr Opin Oncol. 2001 Sep;13(5):394-8. Review.

PMID:
11555719
10.

[Characteristics of uterine cancer detected by mass screening].

Igarashi T, Konno R, Sato S, Yajima A.

Gan To Kagaku Ryoho. 1998 Aug;25(10):1519-26. Review. Japanese.

PMID:
9725043
11.

[The Pap test revisited].

Broso P, Pagani E.

Minerva Ginecol. 1991 Mar;43(3):71-85. Review. Italian.

PMID:
2057106
12.

Is it now time to evaluate the true accuracy of cervical cytology screening? A review of the literature.

Martin-Hirsch PL, Koliopoulos G, Paraskevaidis E.

Eur J Gynaecol Oncol. 2002;23(4):363-5. Review.

PMID:
12214747
13.

Pitfalls in diagnostic cervicovaginal cytology.

Sidawy MK, Solomon D.

Monogr Pathol. 1997;(39):1-15. Review. No abstract available.

PMID:
9249817
14.

Cytologic screening for cervix cancer: each year or each 3 years?

Dubois G.

Eur J Obstet Gynecol Reprod Biol. 1996 Mar;65(1):57-9. Review.

PMID:
8706958
15.

Does a zero error standard exist for the Papanicolaou smear? A pathologist's perspective.

Frable WJ.

Arch Pathol Lab Med. 1997 Mar;121(3):301-10. Review.

PMID:
9111124
16.

Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-1988.

Anderson GH, Benedet JL, Le Riche JC, Matisic JP, Thompson JE.

Obstet Gynecol. 1992 Jul;80(1):1-4. Review.

PMID:
1603476
17.

[Screening for cervix uteri cancer].

BorrĂ s JM, Iglesias X.

Med Clin (Barc). 1994;102 Suppl 1:80-4. Review. Spanish. No abstract available.

PMID:
8170254
18.

Cervical cancer screening programs. I. Epidemiology and natural history of carcinoma of the cervix.

[No authors listed]

Can Med Assoc J. 1976 Jun 5;114(11):1003-12. Review. No abstract available.

19.

Adenocarcinoma of the cervix.

Quinn MA.

Ann Acad Med Singapore. 1998 Sep;27(5):662-5. Review.

PMID:
9919336
20.

Case-control studies of screening.

Moss SM.

Int J Epidemiol. 1991 Mar;20(1):1-6. Review.

PMID:
2066205

Supplemental Content

Support Center